News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioCapital
MedImmune, Inc. To Present At The 2006 UBS Warburg Global Life Sciences Conference
September 19, 2006
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
GAITHERSBURG, Md., Sept. 18 /PRNewswire-FirstCall/ -- MedImmune, Inc. (Nasdaq: MEDI - News) announced today that it will present at the 2006 UBS Global Life Sciences Conference on Monday, September 25, 2006, at 11:30 a.m. eastern time.
Twitter
LinkedIn
Facebook
Email
Print
Events
MORE ON THIS TOPIC
Diabetes
ADA: Lilly bests Novo again, takes GLP-1 pill Foundayo to FDA for diabetes approval
June 9, 2026
·
2 min read
·
Tristan Manalac
Obesity
ADA: Boehringer leans on fat mass benefits as obesity bet delivers ‘less competitive’ weight reduction
June 8, 2026
·
2 min read
·
Tristan Manalac
Obesity
ADA: Metsera asset data support Pfizer’s ‘entry point’ into obesity market
June 8, 2026
·
4 min read
·
Tristan Manalac
Obesity
ADA: Lilly sets ‘new record in Weight Loss Olympics’ with next-gen asset
June 8, 2026
·
2 min read
·
Tristan Manalac
